ACADIA Pharmaceuticals
ACAD
$15.23
Share price
0.13%
Change (1 day)
-28.93%
Change (1 year)
Categories
EPS for ACADIA Pharmaceuticals (ACAD)
EPS in 2023 (TTM): -$0.92
According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.92. In 2022 the company made an earnings per share (EPS) of -$1.34 a decrease over its 2021 EPS that were of -$1.05.
EPS history for ACADIA Pharmaceuticals from 2003 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.92 | -31.34% |
| 2022 | -$1.34 | 27.62% |
| 2021 | -$1.05 | -41.67% |
| 2020 | -$1.80 | 12.5% |
| 2019 | -$1.60 | -17.95% |
| 2018 | -$1.95 | -17.02% |
| 2017 | -$2.35 | 0.43% |
| 2016 | -$2.34 | 43.56% |
| 2015 | -$1.63 | 73.4% |
| 2014 | -$0.94 | 113.64% |
| 2013 | -$0.44 | 18.92% |
| 2012 | -$0.37 | -15.91% |
| 2011 | -$0.44 | -210% |
| 2010 | $0.40 | -133.61% |
| 2009 | -$1.19 | -30.81% |
| 2008 | -$1.72 | 7.5% |
| 2007 | -$1.60 | -0.62% |
| 2006 | -$1.61 | 4.55% |
| 2005 | -$1.54 | -14.61% |
| 2004 | -$1.80 | -84.26% |
| 2003 | -$11.46 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -1,631.01% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -302.17% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | -690.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -531.52% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.27 | -129.35% | 🇺🇸 USA |